eGERD
Commercial- Indications
- Gastroesophageal reflux disease (GERD)
Company intelligence / Profile preview
GerdCare Medical
Israelgerd-care.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
GerdCare Medical has developed the eGERD device, a non-invasive, wearable medical device for the treatment of GERD. Clinical results indicate rapid symptom relief in 75–90% of users within days. The safety and effectiveness of the eGERD device are being evaluated in ongoing clinical trials with endpoints including esophageal acid exposure time and DeMeester score.
- Therapeutic areas
- Gastroenterology
- Modalities
- DeviceDigital therapeutic
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on GerdCare Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GerdCare Medical.